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Abstract 
The barriers to accessibility and availability of essential drugs in public and private health facilities in Calabar 
metropolis, Cross River State, Nigeria has been studied. The study has revealed that all the pharmacists both in 
the private and public sector are aware of the concept of essential drugs and majority of them are of the opinion 
that the goals have not been achieved. The availability of essential drugs in the private sector though adequate 
costs of drugs are a barrier to their accessibility while in the public sector the costs of drugs are higher than in the 
private sector and the level of availability is poor. Factors that lead to the unavailability of these essential drugs 
are multifactorial. These include defects in the distribution and supply of the essential drugs to their points of 
usage, Inadequate funding for purchasing quantities of drugs that are needed, inability to pay suppliers so that 
they do not extend credit facilities to the health facilities .Drugs are wasted through expiries because correct 
quantification is not being done. 
Keywords: Accessibility, Availability, Barriers, Health facilities and Essential drugs 
 
1. Introduction 
Irrational use of medicines such as overuse, underuse and misuse both to the prescriber and the consumer are 
wasteful and hazardous to health of individuals and the population. Overuse of drugs will include 
overprescribing and overconsumption. In developing countries, the medicines that suffer this are the painkillers, 
antibiotics, injections, cough and cold medications. Injections are perceived as being both powerful and fast 
acting, this perception is shared by both prescribers and consumers and the high use is a consequence of both 
their expectations (Le Grand et al, 1999). Uzochukwu et al. (2014) showed that patients incurred additional costs 
through irrational dispensing of medicines by patent medicine vendors in Nigeria especially for treatment of 
acute respiratory tract infections (ARI), diarrhea and malaria .Irrational prescribing is a global problem as in 
Kazakhstan there is increase in the use of expensive, branded medications and reduction in the use of first line 
generics leading to adverse health and economic effects. Even in Nepal, 20%-52%of drugs were wasted through 
irrational prescribing in the primary health centres .This wastage occurs with formally trained health workers and 
consequently will be worse with patent medicine dealers (PMD) with no formal training in common ailments 
(Uzochukwu et al.,2014) . Irrational use of medicines also involves use of too many medicines per person (poly-
pharmacy) or a situation where the number of drugs in the prescription is more than needed. Misuse of drugs is 
using the wrong drug for a specific condition, use of drugs in wrong dosage, drug of doubtful efficacy and safety 
status. 
One of the consequences of irrational use of drugs is adverse drug reaction (ADR) which can result in 
death .They occur very frequently and are preventable. According to White et al. (1999),the direct and indirect 
costs of ADRs in the US annually is between 30.1 -136.8 billion dollars and includes hospital 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal 
Vol.27, 2016 
 
37 
admissions ,emergency room visits and outpatient revisits to physicians .Indirect cost will also include loss of 
productivity and reduction in quality of life. Incidences of ADR-soccur at frequencies that rank among deaths 
attributed to heart diseases, accidents, cancer and stroke. According to Quick (2003) studies in both developed 
and developing countries show that 25-75% of inappropriate use of antibiotics in teaching  hospitals with the 
percentage increasing in primary health centres while less than 50% of people suffering from chronic illness 
such as diabetes and hypertension adhere correctly to their treatment. Inappropriate use of antibiotics cause 
widespread resistance like chloroqujne resistance has been established in 81 out of 92 endemic countries. 
Overuse of injections when the use of oral medications is appropriate, non-adherence to dosing regimen by 
patients, inappropriate self-medication and failure to adhere to clinical guidelines by prescribers (WHO, 
2012).According to le Grand et al., (1999) additional public health consequences of negative impacts of 
irrational drug use are: 
• Limited efficacy of under therapeutic dosage of antinfective agents used to treat infections, 
tuberculosis and leprosy. 
• Drug dependence as in the case of daily use of pain killers and tranquilizers 
• Increase in the use of injections increase the risks of blood borne disorders like abscesses, 
AIDS, hepatitis and polio fromnon-aseptic injection techniques. 
Irrational drug use has economic impact on household and national budgets due to wastage of scarce 
financial resources with the use of expensive branded drugs instead of generics combination therapies and 
multidrug prescribing. This is a worrisome trend as about 64.4%of the Nigerian population lives below the 
poverty line of US$1 per day. (Uzochukwuet al., 2014) 
Rational use of medicines requires that “patients receive medications appropriate to their clinical needs 
in doses that meet their own individual requirements for an adequate period of time and at the lowest cost to 
them and their community ’’. In 1989, the International Network for the Rational Use of Drugs (INRUD) was 
formed to conduct multi-disciplinary intervention research projects to promote more rational use of medicines. 
WHO, 2002 established model selection process for updating lists of Essential medicines and advocates  
that selection be based on treatment guidelines ,systematic reviews of clinical evidence and making the evidence 
publicly available to guide policy makers in decision making. 
Also, there has always been a challenge to social systems on how to achieve fairness in health financing 
and avoid catastrophic payments. The two types of health financing are private insurance premiums and out of 
pocket expenses. Insurance premiums that protect individuals from expenditure are available only to the rich, the 
healthy and a certain class of people in developing countries and in urban areas. Out of pocket expenses are 
made at the point of service and how much individuals are willing to pay and able to purchase will be a function 
of their income Out of pocket financing for health is the major reason for unfairness health financing leading to 
financial losses and increased risk of impoverishment. At the inception of the essential drugs in 1977 it was 
assumed that public financing would be used to procure the drugs. In most low income countries, patients bear 
the cost of drugs of about 50-90% themselves and medicines are largest out of pocket health expenditure. The 
burden of financing medicines in developing countries like Nigeria falls to those most in need and the least able 
to pay especially through private pharmacies and other drug outlets (Quick, 2003). 
Prescribers and end users play important role in the use of medicines as factors like 
knowledge ,attitude ,perception will influence the decision to seek health care and from whom and whether to 
adhere to the recommended treatment especially in chronic diseases. 
The inefficiency, unreliability and insecurity of government drugs supply systems has made private 
sector and non-governmental organizations to have increased role in the supply of medicines. Efficiency in 
medicines supply will result to strong health care systems. The reliable health and supply system integrates 
supply management in the development of the health system, have an efficient mix of public and private partners, 
maintain a continuous distribution channel of quality medicines to ultimately increase access to essential 
medicines. Key components to ensure uninterrupted availability and accessibility are adequate human resources, 
sustainable financing, management information systems and coordination among health care partners and 
institutions. Sub-Saharan Africa lacks long term supply strategies to make this possible (WHO, 2015). 
Steps in efficient management of drug supply are selection, quantification and forecasting, procurement, 
storage and distribution. According to Adenika , 1992 the selection of any drug for any essential  drugs 
programme involves assessment of the prevailing disease, know treatments  of choice and dosage forms and then 
decide the types of drugs available at all health care levels .Careful selection of essential medicines is the first 
step to ensure access.(WHO, 2004). 
Nigeria’s National Drug Policy of 1990 states that criteria for selection are: 
• Drugs that satisfy the health care needs of the great majority of people at all levels of health 
care delivery 
• Drugs whose efficacy and use have been confirmed  with sufficient evidence 
• There should be reasonable shelf life and can withstand unavoidable adverse environmental 
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conditions during distribution 
• Generic names should be used unless where not possible  
• Local manufacture of drugs is encouraged and exported drugs are those that can be certified by 
the country of origin and WHO. 
Drug forecasting and quantification follows selection and is the process of determining the quantity of 
each drug that is needed. For quantification to be effective, specific data containing morbidity and consumption, 
the types of drugs to be available and how they are prescribed should be considered. Parameters to be taken into 
consideration when forecasting to avoid cash being tied to stock or out of stock situations are; 
• Available financing 
• Stock on hand at all levels of distribution system 
• Orders that are expected to be delivered  
• Expected losses through expiry or damage 
• Medicines donations 
• Desired stock at end of each planning period (safety and working stock at all levels) 
Drug quantification is an integral part of the drug logistics management and can only be sustained with 
high level and long term commitment. Inefficient quantifications is very common in Nigeria and is caused by 
lack of systematic procedures, lack of reliable data on morbidity and consumption, lack of consensus on the most 
cost effective procedures and pressures from various sources and interests groups. The result of poor 
quantification is to reduce access and availability of essential drugs and is displayed as: 
• Chronic and widespread shortages of commonly prescribed and used drugs despite adequate 
funding, procurement and distribution. 
• Overestimation of quantities resulting in surpluses of a large number of commonly used drugs 
or large supply of a smaller number of drugs.  
• Irrational and ineffective prescribing due to inadequate or inappropriate drug supplies in order 
to stretch insufficient drug supplies as much as possible.  
Procurement involves efforts to quantify medicines requirements, selecting appropriate procurement 
methods, prequalifying suppliers and products. It also involves managing tenders, establishing contract terms, 
assuring medicines quality, obtaining best prices, and ensuring adherence to contract terms. Procurement 
methods need to be strengthened to ensure that procurement is linked to national medicines lists and prescribing 
patterns (WHO, 2015).Failure in any of these areas leads to lack of access to appropriate drugs and waste. Lack 
of guarantees and access to fund when needed leads to procurement inefficiencies and drug shortages .Limited 
and irregular funding leads to delays in payments to suppliers and they will deny credit or insist on advance 
payments. Financial autonomy for the health system with flexibility ensures efficient management of the system. 
Storage involves keeping medicines in good condition throughout the drug supply cycle appropriate 
physical conditions and the storage procedures must be maintained at every point in the distribution to ensure the 
quality and efficacy of the commodities. Forecasted quantities of drugs should be able to it into the store room or 
phased delivery done if the capacity is inadequate. 
An appropriate store for essential drugs must have separate space for the following: deliver and receipt 
of products, main storage, expired items, inflammable products, controlled substances, products requiring cold 
chain. Storage equipment is often inadequate and sometimes the medicines are placed directly on the floor 
instead of on pallets. 
Distribution system ensures a constant supply of medicines while product quality and integrity is 
maintained throughout the distribution channel of the medicines.  Medicines are kept in good   and appropriate 
conditions throughout the process so as to minimize medicines loss due to spoilage and expiry, keep accurate 
inventory records, rationalize medicines storage points, use available transportation resources efficiently, and 
reduce theft and fraud. 
Distribution from the main storage point to a lower level store or health facility may follow the push or 
pull system or a combination of both. The choice of a push or a pull system depends on the needs of the health 
facility.  In the pull system medicines requests are sent from the lower level. Adequate human resources are 
required to calculate medicines needs to last for a certain defined period of distribution and the central medical 
stores distributes products to all lower health facilities with its own transportation system or the  responsibility of 
transporting the products from the central medical stores to the facilities is that of the individual health facilities. 
The push system is used in emergency situation where there is no adequate storage space or personnel 
to manage a range of products as aa limited list of products is pushed from the central medical stores to the 
health facilities during a defined time frame. This system is also used when starting a new medicines program 
where there are no previous consumption data, but in practice a combination of the two systems are used. 
After personnel cost ,medicines are the largest government health service cost and the largest part of 
household health expenditure .So that governments ,health care providers and individuals  in developing 
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countries are highly sensitive to the prices of medicines .The combined effects of add-on prices from 
taxation ,middle men ,distribution costs and retail margin results in the final price to the consumer that is more 
than double the producers or importers price.(Quick, 2003).The price of drugs matter to poor people in poor 
countries even though prices of drugs alone does not determine who gets access to health care. But if the price is 
set at the level the consumer cannot afford, the drugs will not be bought. (WHO, 2001). The prices of newer 
essential drugs are a matter of concern due to the capital intensive process of research and development of drugs. 
The World Trade Organization through the Trade Related Aspects of Intellectual Property Rights (TRIPS) has 
established minimum time for product patent and to make these newer medicines available for millions of people 
these agreements have to be clarified (Quick, 2003). 
The circulation of substandard medicines in the developing world is a serious public health problem that 
affects the accessibility of drugs and is of clinical concern to health care workers as they are faced with this 
every day. The effects of substandard medicine include fatal toxicity even though the effects go unnoticed except 
in cases resulting in mass deaths. Aspects of counterfeiting involve under or overconcentration of ingredients, 
poor quality of ingredients, contamination, poor stability of the ingredients and poor or inadequate packaging. 
The consequences of this can range from lack of active ingredients leading to treatment failure  often 
resulting prolonged illness and death and promotion of drug resistance in case anti-infective agents, (Caudron et 
al., 2008). Another aspect of quality is counterfeit and fake drug that is related to drug supply. WHO (2006 c) 
defined  counterfeit/fake drugs as drugs that can deliberately and fraudulently mislabeled with respect  to identity 
/source. Counterfeiting applies to generic and branded products and includes products without active ingredients, 
wrong ingredients or insufficient active ingredients with fake packaging. 
Substandard drugs are generic drug products that do not meet the international standards and 
specifications set for them in terms of quality, purity strength or packaging. (Smine, 2002) 
Causes of poor quality include: 
a) Poor compliance with GMP (good manufacturing practice)with high standards of production for 
countries and agencies with stringent regulations .An intermediate standard for other countries and 
yet much lower standards for countries with poor regulations. 
b) Drug purchases especially by developing countries are not done with adequate reference to quality 
standards  
According to WHO, (2004a), only one in six countries have fully functional drug regulatory 
systems .Even though drug registration is a prerequisite for purchases in developing countries ,control of quality 
cannot be assured. Taylor et al., (2001) in a random sample  of antibiotic and anti-parasitic drugs found that 
almost half did not comply with set Pharmacopoeial standards resulting in treatment failures and drug resistance. 
Counterfeit drugs are a consequence of lack of access to essential drugs and it thrives in a place where drugs are 
scarce and prices are high (Chike et al., 2011). 
The objective of this study is to probe the barriers to accessibility and availability of essential drugs in 
public and private health facilities in Calabar metropolis, Cross River State, Nigeria. The Calabar metropolis 
comprises: Calabar South and Municpal Local Government Area (LGA) Councils. A survey in the metropolis 
was conducted to arrive make a claim. 
 
2. Material and Methods 
2.1 Study Setting 
Cross River State is one of the states in the South-South Geopolitical zone in Nigeria with Calabar as its state 
capital. It is located at the southernmost part of the country and has boundaries with Akwa Ibom State to the west, 
north by Benue and Ebonyi States while it has international borders with Cameroon, Equatorial Guinea and the 
Atlantic Ocean. The state comprises of 18 local government areas with a total population of 2,817,626 with 
1,459,530 males and 1,358,096females according to the 1991 population census.(Essien, 2005).There are a total 
of 402 health care facilities with a tertiary hospital ,state owned general hospitals and primary health care centres 
with several private owned pharmacy shops and drug outlets. There is a central EDP store that caters to all the 
health care centres in the state. Calabar South and Calabar municipality were chosen as representative local 
Government areas from the eighteen in the state. 
 
2.2 Study Design  
The study used a cross sectional descriptive study design usedto examine the factors that affect the essential 
drugs accessibility and availability. The descriptive study was considered to be appropriate because it provided 
reliable information and gave adequate description of a situation and not make generalization beyond the 
obvious.(Essien, 2005).The level of accessibility of essential drugs was based on the protocol developed by 
HAI/WHO (2009). To standardize the methodology, specific dosage forms and strength of each medicine 
surveyed was included. Medicines selected were based on HAI/WHO core list of 14 globally accepted medicines 
with additional 7 medicines based on local relevance used to treat a range of chronic and acute conditions. For 
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each of the medicines, price data was collected on originator and the lowest priced generic at each facility. 
Structured questionnaires were administered to hospital pharmacists and superintendent pharmacists of 
consenting private pharmacies to investigate the factors that affect the accessibility and availability of essential 
drugs in the state. 
 
2.3  Population/Sample Characteristics 
The study population is made up of registered pharmacists of both public and private sector working in Calabar 
Municipality and Calabar South local Government .The population is finite and made up of both male and 
female. 
 
2.4  Inclusion Criteria 
Consenting pharmacists working in the public and private sectors. 
 
2.5  Size of the Sample 
The size of the sample was determined from the list of registered pharmacists in Calabar obtained from the 
Association of Hospital & Administrative Pharmacists of Nigeria , and Association of Community Pharmacists 
of Nigeria, Calabar Branch. 
 
2.6  Data Collection Instrument 
Data was collected using researcher administered structured questionnaire (Appendix 1) and sighting of the 
drugs .Two intern pharmacists were trained in collecting data from the pharmacy shops while the researcher 
carried out the data collection in the hospital. The questionnaire was pre –tested in Akpabuyo Local Government 
area to validate and corrections made before the final distribution and collection. 
 
2.7 Data Analysis 
The availability of individual medicines was calculated as percentage (%) of the health facilities where the 
medicines were found both for originator brands and generic brands .The accessibility was calculated in terms of 
affordability and as the cost of treatment of 30 days for chronic conditions and a full course of therapy for acute 
conditions when compared to the daily minimum wage of a government worker of N600.00 (Naira) per day .The 
price of medicines used was the median price of the lowest priced generic. Pretested questionnaires were also 
administered on hospital pharmacists and consenting superintendent pharmacists of private pharmacies.Data 
obtained was analyzed using Statistical package for Social Sciences (SPSS) for descriptive studies and presented 
in frequency tables and bar charts. 
 
2.8  Ethical Approval 
Ethical approval was sought and gotten from The Cross River State Health Research Ethics Committee (CRS-
HREC) with REC.NO.RP/REC/2015/295. Informed written consent was obtained from all respondents before 
administering questionnaires to them. 
 
3. Results 
3.1 Sociodemographic Data 
Table 1. Age distribution of respondents 
 Frequency (%) 
21 – 30 38 (41.3) 
31 – 40 47 (51.1) 
41 – 50       7 (7.6)  
Total        92 (100.0) 
 
Table 2. Sex distribution of the respondents 
 Private Public  Total  
Female  5 (5.4%) 26(28.2%) 31 (33.7%) 
Male  27(29.3%) 34(37.0 %) 61(66.3%) 
Total  32 (34.8%) 60 (65.2%) 92(100.0%) 
p>0.05 (NS) 
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Table 3. Educational qualification of respondents 
 Frequency (%) 
B.Pharm 82(89.2) 
FPCP 4(4.3) 
M. SC 4 (4..3) 
Ph.D. 2 (2.2) 
Total  92 (100.0) 
Tables 1-3 show the demographic characteristics of the respondents. The respondents who were 
pharmacists were 92 in number with 61(66.3%) males and 31(33.7%) females. Most of them were between the 
ages of 31-40 years. About 82 (89.2%) had B. Pharm only as the least professional qualification with 4 (4.3%) 
being fellows,4(4.3%) with M.Sc. and 2(2.2%) with PhD with 32(3.8%) working in private pharmacy shops 
while 60(65.2%) worked in the public sector being hospital pharmacists. 
 
3.2 Characteristics of health facility 
Table 4. Type of health facility of the respondents 
 Private Public  Total  
Primary  0 (0.0%) 0 (0.0%) 0 (0.0%) 
Secondary   0 (0.0%) 10(10.9%) 10(10.9%) 
Tertiary  0 (0.0%) 50(54.3%) 50(54.3%) 
Pharmacy  
Total             
32 (34.8%) 
32(34.8%) 
0(00.0%) 
60(65.2%) 
32(34.8%) 
92(100.0%) 
Chi cal. = 12.000; df = 1; p<0.05 
Table 4 shows the level of practice of the respondents with majority of them in the tertiary institutions 
being 50 (54.3%), 10(10.9%) in secondary institutions   while the community pharmacists that consented to be 
interviewed were 32 (34.8%). 
Table 5. Availability of essential medicines list in the health facilities 
 Private Public  
Available 16 (50.0%) 60(100.0%) 
Not available  16 (50.0%) 0 (0.0%) 
p>0.05 (NS) 
Table 6.  Services provided in the health facility of the respondents 
 Private Public  Total  
Out-patient care only 32 (100.0%) 0 (0.0%) 32 (100.0%) 
Out-patient and in-patient care   0 (0.0%) 60 (100.0%) 60 (100.0%) 
Maternal and child health  0 (0.0%) 60 (100.0%) 60 (100.0%) 
Medical cases only 0 (0.0%)  (00.0%) 0 (0.00%) 
Medical and surgical care 0 (0.0%) 60 (100.0%) 60(100.0%) 
Chi cal. = 12.000; df = 1; p<0.05 
 
3.3 Awareness of essential drugs and goals 
Table 7. Awareness of the concept of essential drugs by the respondents 
 Private Public  
Aware 32(100.0%) 60 (100.0%) 
Not aware 0 (0.0%) 0 (0.0%) 
p>0.05 (NS) 
 
Table 8. Achievement of the goals of essential drugs 
 Private Public  
Achieved 11 (34.4%) 18 (33.3%) 
Not achieved 21 (65.6%) 42(66.7%) 
p>0.05 (NS). 
Table 7 shows that all the respondents were aware of the concepts but differed in their opinion as to the 
attainment of the goals of essential drugs as shown in Table 8. But majority of the pharmacists both in the private 
sector and public sector (more than 65.0%) said the goals had not been achieved. 
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Table 9. Sources of drugs in the health facility of respondents 
 Private Public  
Central medical stores  0 (0.0%) 20 (33.3%) 
Drug manufacturing companies   27 (84.4%) 40(66.7%) 
Open market  5 (15 .6%) 0 (0.0%) 
Donation  0 (0.0%) 0 (0.0%) 
p>0.05 (NS) 
For the public or government owned pharmacies, 40(66.7%) dispensed drugs obtained from their 
central medical stores while the rest obtained drugs directly from drug manufacturing companies. 
 
3.4 Barriers to Accessibility of Essential Drugs 
Table 10. Barriers to accessibility of essential drugs  
 Barrier  
(%) 
Not a barrier (%) Indifferent 
(%) 
High cost of drugs 52(56.5) 40(43.5) 0(0.0) 
Too many drugs 20(21.7) 69(75.1) 3(3.2) 
Attitude of pharmacist 17(18.5) 72(78.3) 3(3.2) 
Unavailability of all prescribed drugs 48(52.1) 37(40.2) 7(7.7) 
Unavailability of drugs 61(66.3) 31(33.7) 0(0.0) 
Table 10 shows the results to the barriers to access to essential drugs from the perspective of the 
pharmacists. About 56.5% of the respondent felt that price or the high cost of drugs was a barrier while 43.5% 
did not see price as a barrier and felt that the patient will buy the drugs at any cost. 
Prescription of too many drugs or polypharmacy did not constitute a barrier to 75.1% of the respondents 
while to 21.7% it was, while 3.2% of the respondents were indifferent. 
Majority of the respondents believed that the attitude of the pharmacists to the patient   was not a barrier 
to access while 18.5% believed it was as it would determine if the patient purchased the drugs while 3.2% were 
indifferent. 
About 52.1 % and 66.3%of the respondents believed that unavailability of all the prescribed drugs in a 
prescription and unavailability of the drugs in general constituted a major barrier to access while 40.05% and 
33.7% did not think it was a barrier. 
 
3.5 Factors affecting availability of Essential Drugs  
Table 11. Factors affecting availability of essential drugs  
 Agree   
(%) 
Disagree   
(%) 
Indifferent 
(%) 
Not delivered on time 55.6 40.7 3.7 
Lack of staff training on drug request 11.1 85.2 3.7 
Lack of staff training on logistics / inventory  
 
48.1 51.9 0.0 
Poor funding 92.6 7.4 0.0 
Prescription outside essential drug lists  
 
70.4 25.9 3.7 
High cost of drugs 29.6 66.7 3.7 
Supplies not being paid 88.9 11.1 0.0 
Infrequent drug prescription 
 
33.3 66.7 0.0 
Loss of drug to pilferage 25.9 66.7 7.4 
Wastage of drugs 66.7 25.9 7.4 
Shown in Table 11 are the results on the factors responsible for the unavailability of essential drugs. 
More than 50% of the respondent believed that late delivery of drugs by suppliers to central medical stores and 
to the dispensing units were responsible for the unavailability of essential drugs. 
About 95.2% agreed  that  inadequate and poor funding so as to enable essential drugs to be purchased  
and about  88.9% agreed that  the debt being owed to  drug suppliers  have made it impossible for them to supply 
drugs  on credit often insisting on cash payments. 
The writing of drug prescription outside of the essential drug lists have also led to the unavailability of 
essential drugs. 
82.5% of the respondents disagreed with the notion that staff lacked essential training on logistics and 
inventory management and do not know when and how to request for the needed drugs. 
66.7% did not agree that high costs of drugs infrequent prescriptions for rare medical conditions led to 
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their unavailability. 
About 66.7% of the respondents agreed that drugs were lost due to pilferage but rather due to wastage 
from expiration and damage. 
 
4.0 Discussion 
This study shows that the majority of the respondents were males (66.3%)and more also in the private sector 
than in the public sectors .The reason being that more males are adapted to the pharmaceutical environment 
while more females were in the hospital sector (28.2%) than in the community practice.51.1% of the  
respondents were between the ages of 31-40 is the more productive ages of the work force .Majority of the 
respondents(89.2%) had Bachelor of Pharmacy as the highest qualification  and the scenario is not acceptable as 
higher qualifications leads to higher quality of care. Pharmacist s role in the health setting is evolving and they 
need to be trained to meet this demand. 
Characteristics of health facility showed that 34.8% were in the private sector while 65.2% of the 
respondents involved in public drug outlets showing that they had first-hand experience of the situation.100% of 
the facilities had alternative power supply indicating that the storage of drugs was at a favourable temperature 
and quality  assured. 84.4% sourced their drugs directly from drug manufacturing companies ensures that 
counterfeit medicines are not purchased and also ensures quality. 
The barriers to accessibility according to respondent were high cost of drugs (56.5%) and availability of 
drugs (52.1%). According to Bansal and Purohit (2013) the availability of medicines is influenced by insufficient 
health facilities and staff, poor medicine supply, low funds investment in health and lack of affordability .This is 
the case as found in our study where the majority of patients are found to purchase medicine from the private 
sector with higher prices or forgo treatment entirely but the prices of the medicines in our study was higher in the 
public sectors when available than in the private sectors. 
According to WHO (2003) medicine availability in the public sector is lower than in the private sector 
and this has been the case in this study. Availability is reported as the percentage of the medicine outlets where 
the medicine was found on the day of data collection. In a study conducted by Tumwine et al., (2010) the most 
important reason given for lack of availability was lack of funds and due to this the quantity of drugs purchased 
is less and cannot meet the demands of the populace. Wangu and Osuga (2014) also reported that stock-outs of 
medicines were caused by poor distribution but in this study, 92.6% of the respondent attributed the lack of 
availability to poor funding while 55.6% attributed this to poor and inefficient delivery and supply systems. 
Irrational prescription and prescription outside the essential drug list was attributed by 70.4% of the 
respondent for lack of availability. Inappropriate drug prescriptions delays correct diagnosis and treatment ,drug 
resistance ,drug interactions and adverse events are increased and wastage of the drugs that should have been 
used for the correct condition .Rational use means that patients will receive medications that are appropriate to 
their needs ,in adequate doses to meet these needs for an adequate period of time and at the lowest cost to them 
and the community .Another opinion is unavailability of suitable drugs alternatives lead to irrational prescription 
and the use of medicines is also influenced by factors such as lifestyle, habits and knowledge of the health care 
personnel (Youseffi et al., 2012). 
Drugs not delivered on time were ascribed by 55.6% of respondents responsible for unavailability. 
Yusuf and Tayo (2004) in a study found that public drug supply in Nigeria is governed by the National Drug 
Policy of 1990 and the strategy used are the Central Medical Store system and in this study, 33.3% of the  
respondents  obtained their drugs from the central medical stores. Financing of drug supply is by the various 
government agencies and is inadequate to ensure sustained availability of essential drugs. The factors responsible 
for this in this study  was also highlighted by Yusuf and Tayo (2004) .Procurement methods involve open tender 
and direct purchase .These methods contribute to stock outs and late order placement ,delay in payment and poor 
supplier lead time due to lateness in payment for previous supplies. 
 
5.0  Conclusion 
This study revealed that all the pharmacists both in the private and public sector are aware of the concept of 
essential drugs and majority of them are of the opinion that the goals have not been achieved. The availability of 
essential drugs in the private sector though adequate costs of drugs are a barrier to their accessibility while in the 
public sector the costs of drugs are higher than in the private sector and the level of availability is poor. Factors 
that lead to the unavailability of these essential drugs are multifactorial. These include defects in the distribution 
and supply of the essential drugs to their points of usage, Inadequate funding for purchasing quantities of drugs 
that are needed, inability to pay suppliers so that they do not extend credit facilities to the health facilities .Drugs 
are wasted through expiries because correct quantification is not being done. 
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